Unicycive Therapeutics, Inc. (UNCY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1975 West El Camino Real
Mountain View, CA 94040
United States of America (the)
Phone
650 351 4495
Website
Sector
Healthcare
Industry
Biotechnology
Employees
21
First IPO Date
July 12, 2021
| Name | Title | Pay | Year Born |
| Shalabh K. Gupta | Founder, Chairman, Chief Executive Officer & President | 1.06M | 1973 |
| John W. Townsend | Chief Financial Officer | 197,864 | 1962 |
| Douglas Jermasek | Executive Vice President of Corporate Strategy | 440,138 | 1961 |
| Pramod Gupta | Executive Vice President of Pharmaceutical and Business Operations | 666,900 | 1960 |
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.